Evidence map›Paper›PMID 32345671›Full record

ArticleCancer genomics & proteomics

The Role of Circulating Adiponectin and SNP276G>T at

Antonella Daniele, Angelo Virgilio Paradiso, Rosa Divella, Maria Digennaro, Margherita Patruno, Stefania Tommasi, Brunella Pilato, Antonio Tufaro, Michele Barone, Carla Minoia and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Cancer genomics & proteomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. The burden of cancer in metabolic dysfunction-associated steatotic liver disease.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Antonella DanieleExperimental Oncology and Biobank Management Unit - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy anto.dani27@gmail.com.
Angelo Virgilio ParadisoExperimental Oncology and Biobank Management Unit - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Rosa DivellaExperimental Oncology and Biobank Management Unit - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Maria DigennaroExperimental Oncology - Center for Study of Heredo-Familial Tumors - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Margherita PatrunoExperimental Oncology - Center for Study of Heredo-Familial Tumors - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Stefania TommasiMolecular Diagnostics and Pharmacogenetics Unit - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Brunella PilatoMolecular Diagnostics and Pharmacogenetics Unit - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Antonio TufaroExperimental Oncology and Biobank Management Unit - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Michele BaroneGastroenterology Section, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
Carla MinoiaOnco-Hematology Unit - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Donatella ColangeloClinical Pathology Laboratory - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Eufemia SavinoClinical Pathology Laboratory - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Porzia CasamassimaClinical Pathology Laboratory - IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Eleonora BrunoEpidemiology and Prevention Unit - Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Andreina OliverioEpidemiology and Prevention Unit - Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Patrizia PasanisiEpidemiology and Prevention Unit - Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Istituto Tumori Bari · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnvironmental factors may influence the lifetime risk of cancer (penetrance) in women with a BRCA mutation. MATERIALS AND

methodsIn 89 BRCA-mutant women, affected or unaffected by breast/ovarian cancer, we explored serum levels of adipokines and their relation with the polymorphism SNP276G>T as modulators of BRCA penetrance.

resultsAffected women had significantly lower adiponectin than healthy women. Affected women with rs1501299 TT had significantly lower adiponectin and higher leptin than GT and GG genotypes. GT genotype was significantly associated with the disease status [odds ratio (OR)=3.24, 95% confidence interval (95% CI)=1.03-10.17]. Women in the lower tertile of serum adiponectin had a RR of BRCA-associated cancer of 2.80, 95% CI=1.1-7.1 (p for trend=0.03) compared with women in the higher tertile.

conclusionIn the SNP rs1501299 the T allele was significantly associated with lower serum levels of adiponectin in affected women, suggesting that the T allele might be related to cancer.

Indexed as

MutationAdiponectinBiomarkers, TumorBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMiddle AgedOvarian NeoplasmsPolymorphism, Single NucleotidePrognosisRetrospective StudiesAdiponectinADIPOQ protein, humanBiomarkers, TumorBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanadipokinesADIPOQ polymorphismBRCA-associated cancerBRCA mutation

Identifiers

PMID32345671
PMCPMC7259884
OpenAlexW3020514314

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.